Kymera Therapeutics (KYMR) Stock Forecast: StockMap's 2-Week Call

KYMR stock forecast: StockMap's model makes no two-week call on Kymera Therapeutics after the Nov 13 close: its evidence is split, 5 reasons for and 10 against. Right in 1 of 3 two-week windows on KYMR since Sep 25; by chance, a call on the same dates was right 51% of the time.

Kymera Therapeutics last closed at $127.57, +0.31% on the session.

Against the IVW growth benchmark the position is +1.22% over the forecast window.

Kymera Therapeutics' market cap is $10.89B as of November 13, 2026.

No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -1 (too close to call).

Where KYMR sits: sized by market cap, coloured by the day's move.

The read is built from 15 underlying insights — 5 bullish and 10 bearish.

Agreement across those insights is 67%.

15 daily calls for KYMR so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Kymera Therapeutics in the 26th percentile on return on equity, where 100 is best.

Kymera Therapeutics is classified under Health Care / Biotechnology.

StockMap tracks Kymera Therapeutics as the 26th largest of the 391 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 186 Moderate Underperform, 157 Neutral, 33 Strong Underperform and 15 Moderate Outperform.

On that composite Kymera Therapeutics ranks 77th of 391 in the group, against a group median of -0.24.

Other Health Care stocks

Research and education, not investment advice. The calls on this page come from StockMap's automated model, run on the close of November 13, 2026, and are the same for every reader. Calls are graded in public, misses included: how calls are graded, and the record. Who makes the calls and who pays for the site: Disclosures.

Kymera Therapeutics (KYMR) — StockMap 2-week forecast & tracked accuracy